TMPRSS2–ERG gene fusion status in minute (minimal) prostatic adenocarcinoma

TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy

(2009) Anuradha Gopalan et al.   CANCER RESEARCH

TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas

(2009) Tamara L Lotan et al.   MODERN PATHOLOGY

The clinical management of patients with a small volume of prostatic cancer on biopsy: What are the risks of progression?

(2008) Patricia Harnden et al.   CANCER

Pleiotropic Biological Activities of Alternatively Spliced TMPRSS2/ERG Fusion Gene Transcripts

(2008) J. Wang et al.   CANCER RESEARCH

Characterization of TMPRSS2-ERG Fusion High-Grade Prostatic Intraepithelial Neoplasia and Potential Clinical Implications

(2008) J.-M. Mosquera et al.   CLINICAL CANCER RESEARCH

TMPRSS2:ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis

(2008) O. R. Saramaki et al.   CLINICAL CANCER RESEARCH

Gene Panel Model Predictive of Outcome in Men at High-Risk of Systemic Progression and Death From Prostate Cancer After Radical Retropubic Prostatectomy

(2008) John C. Cheville et al.   JOURNAL OF CLINICAL ONCOLOGY

Do patients with low volume prostate cancer have prostate specific antigen recurrence following radical prostatectomy?

(2008) B Furusato et al.   JOURNAL OF CLINICAL PATHOLOGY